Quebec: Health Minister Tony Clement has said that Canada is ready to tackle any worldwide pandemic outbreak as a Quebec City-based influenza vaccine production facility is near completion.
Pharmaceutical giant GlaxoSmithKline (NYSE:GSK), owns the facility, which is in the final stages of the nearly $200-million expansion.
Clement said that in past few years the fast efforts to get ready for an outbreak have been made.
Toronto: The Canadian researchers are launching a large multi-year international study, in order to find a way to help the men diagnosed with prostate cancer.
Mumbai: Ajanta Pharmaceuticals has signed an licensing contract with Canada-based Prollenium Medical Technologies to exclusively market the latter’s dermal filler ‘Revanesse’ in the Indian market.
A message from Ajanta Pharmaceuticals said that the Prollenium Technologies has its proficiency in “medical aesthetics.”
The note added that revanesse adds volume and polishes out deficiencies in the skin and also helps protect delicate skin areas from maturating.
According to a new report, colorectal cancer screening is under-use in Canada. The main reasons for under-use of colorectal cancer screening procedures include, talking about that part of body is not easy to do, and lack of organized provincial screening programs across the country.